Synapse Investment
Startup rounds since 2014 with a Synapse Investment investor on the board, and the firm's own fund filings.
Raises
28
since 2014
Unannounced
0
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name
Rounds
- FORE US Bio Inc.$70.4M
- Avenzo Therapeutics, Inc.$47.2M
- Rezo Therapeutics, Inc.$68.1M
- Avenzo Therapeutics, Inc.$386M
- ADARx Pharmaceuticals, Inc.$200M
- ADARx Pharmaceuticals, Inc.$46M
- Dren Bio, Inc.$62.5M
- ARS Pharmaceuticals, Inc.$55M
- ADARx Pharmaceuticals, Inc.$75M
- Dren Bio, Inc.$25.5M
- Palleon Pharmaceuticals Inc.$100M
- Navitor Pharmaceuticals, Inc.$20.2M
- Navitor Pharmaceuticals, Inc.$11.3M
- TP Therapeutics, Inc.$80M
- Principia Biopharma Inc.$50M
- Bird Rock Bio, Inc.$2.5M
- Progyny, Inc.$14.8M
- Effector Therapeutics, Inc.$56M
- Bird Rock Bio, Inc.$5M
- Principia Biopharma Inc.$15.3M
- Adheron Therapeutics, Inc.$1.5M
- Effector Therapeutics, Inc.$36.2M
- Avhana Health, Inc.$676K
- Htg Molecular Diagnostics, IncUndisclosed
- Htg Molecular Diagnostics, IncUndisclosed
- IlluminOss Medical Inc$6.47M
- Ruiyi, Inc.$5M
- Htg Molecular Diagnostics, Inc$7.48M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 1 | 0 |
| 2025 | 2 | 0 |
| 2024 | 1 | — |
| 2023 | 2 | — |
| 2022 | 1 | — |
| 2021 | 2 | — |
| 2020 | 3 | — |
| 2019 | 1 | — |
| 2018 | 2 | — |
| 2017 | 1 | — |
| 2016 | 3 | — |
| 2015 | 5 | — |
| 2014 | 4 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Synapse Investment, LP | 9 Sep 2025 | Open-ended | — |
Listed because a Synapse Investment fund's filing names a director of each company. A name match is not a verified identity.